Search Results
Cancer Cell : Papers Under Review

Viewing: 1 - 20 of 68 papers

1.

Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

A. Gordon Robertson
Dxige Research Inc.
Khyati Meghani
Northwestern University - Department of Urology
Posted: 15 Sep 2021
Publication Status: Under Review
Downloads 10
2.

Transcriptional Profiling of Macrophages in situ in Metastatic Melanoma Reveals Localization-Dependent Phenotypes and Function

Jan Martinek
The Jackson Laboratory - Jackson Laboratory for Genomic Medicine
Jianan Lin
The Jackson Laboratory - Jackson Laboratory for Genomic Medicine
Posted: 11 Aug 2021
Publication Status: Review Complete
Downloads 3
3.

TREM2 Sensing of Tumor Cell Efferocytosis Promotes a Macrophage Molecular State that Limits NK Cell Antitumor Immunity

Ivan Reyes-Torres
Mount Sinai Health System - Precision Immunology Institute
Matthew Park
Mount Sinai Health System - Precision Immunology Institute
Posted: 05 Aug 2021
Publication Status: Review Complete
Downloads 9
4.

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort Study

Alfredo Addeo
University of Geneva - Department of Oncology
Pankil Shah
University of Texas at San Antonio - Population Health Sciences
Posted: 01 Jun 2021
Publication Status: Published
Downloads 6
5.

Single-Cell Landscapes of Primary Glioblastomas and Matched Organoids and Cell Lines Reveal Variable Retention of Inter- and Intra-Tumor Heterogeneity

Veronique G. LeBlanc
BC Cancer Agency (BCCA) - Canada's Michael Smith Genome Sciences Centre
Diane L. Trinh
BC Cancer Agency (BCCA) - Canada's Michael Smith Genome Sciences Centre
Posted: 12 May 2021
Publication Status: Under Review
Downloads 17
6.

Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma

Lewis Au
Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory
Emine Hatipoglu
University College London - Cancer Immunology Unit
Posted: 26 Mar 2021
Publication Status: Review Complete
Downloads 17
7.

PD-1 Blockade Therapy Promotes Novel Infiltration of Tumor-Specific T-Cell Clonotypes

Joji Nagasaki
Chiba Cancer Center - Research Institute
Takashi Inozume
Chiba Cancer Center - Research Institute
Posted: 02 Mar 2021
Publication Status: Review Complete
Downloads 25
8.

Mesothelial Cell-Derived Antigen-Presenting Cancer-Associated Fibroblasts Induce Expansion of Regulatory T Cells in Pancreatic Cancer

Huocong Huang
University of Texas Southwestern Medical Center - Department of Surgery
Zhaoning Wang
University of Texas Southwestern Medical Center - Department of Molecular Biology
Posted: 22 Feb 2021
Publication Status: Review Complete
Downloads 11
9.

The AML Microenvironment Catalyzes a Step-Wise Evolution to Gilteritinib Resistance

Sunil Joshi
Oregon Health and Science University - OHSU Knight Cancer Center Institute
Tamilla Nechiporuk
Oregon Health and Science University - OHSU Knight Cancer Center Institute
Posted: 22 Jan 2021
Publication Status: Published
Downloads 57
10.

Bevacizumab Plus Erlotinib in Chinese Patients with Untreated, EGFR-Mutated, Advanced NSCLC (ARTEMIS-CTONG1509): A Multicenter Phase 3 Study

Qing Zhou
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Ying Cheng
Jilin Provincial Tumor Hospital - Department of Thoracic Oncology
Posted: 19 Dec 2020
Publication Status: Accepted
Downloads 21
11.

Durvalumab With Olaparib and Paclitaxel for High-Risk HER2-Negative Stage II/III Breast Cancer: Results From the Adaptively Randomized I-SPY2 Platform Trial

Lajos Pusztai
Yale University
Christina Yau
University of California, San Francisco (UCSF)
Posted: 19 Dec 2020
Publication Status: Published
Downloads 7
12.

Allergic Mediator Histamine Confers Immunotherapy Resistance in Cancer Patients via Histamine Receptor 1 on Macrophage

Hongzhong Li
The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology
Yi Xiao
The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology
Posted: 18 Nov 2020
Publication Status: Review Complete
Downloads 13
13.

Hepatitis B Virus Drives Divergent Adaptive Immunity in Hepatocellular Carcinoma

Liang Chen
Stanford University - Department of Microbiology and Immunology
Maojun You
Chinese Academy of Sciences (CAS) - Key Laboratory of Infection and Immunity of CAS
Posted: 28 Oct 2020
Publication Status: Review Complete
Downloads 17
14.

A Novel Combination of Decitabine and Etoposide Greatly Improves the Survival of TP53 Mutation AML/MDS Patients by Targeting Notch1 Signaling Pathway

Jiexian Ma
Fudan University - Department of Hematology
Shunrong Sun
Fudan University - Department of Hematology
Posted: 20 Oct 2020
Publication Status: Review Complete
Downloads 5
15.

Single-Cell RNA Sequencing Reveals PD-L1+ Fibroblasts as a Determinant of Immune Exhaustion in Pancreatic Cancer Microenvironment

Yi Zhao
Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Immunology
Shiwei Guo
Changhai Hospital - Department of Pancreatic Hepatobiliary Surgery
Posted: 19 Oct 2020
Publication Status: Review Complete
Downloads 13
16.

Network-Based Assessment of HDAC6 Activity is Highly Predictive of Pre-Clinical and Clinical Responses to the HDAC6 Inhibitor Ricolinostat

Tizita Zeleke
Icahn School of Medicine at Mount Sinai Hospital - Graduate School
Qingfei Pan
St Jude Children’s Research Hospital - Department of Computational Biology
Posted: 15 Oct 2020
Publication Status: Review Complete
Downloads 7
17.

Ethnicity-Specific Variation in the Germline Landscape of Renal Cell Carcinoma

Sarah Abou Alaiwi
Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology
Amin Nassar
Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology
Posted: 15 Oct 2020
Publication Status: Review Complete
Downloads 15
18.

Co-Occurring Gain-of-Function Mutations in HER2 and HER3 Modulate HER2/HER3 Activation, Breast Cancer Progression, and HER2 Inhibitor Sensitivity

Ariella Hanker
UTSW Simmons Comprehensive Cancer Center
S. Harikrishna
Vanderbilt University - Department of Chemistry
Posted: 12 Oct 2020
Publication Status: Published
Downloads 12
19.

Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART® Molecule

Alexey Berezhnoy
MacroGenics, Inc.
Bradley J. Sumrow
MacroGenics, Inc.
Posted: 09 Oct 2020
Publication Status: Review Complete
Downloads 8
20.

Neoplastic and Immune Single Cell Transcriptomics Define Subgroup-Specific Intra-Tumoral Heterogeneity of Childhood Medulloblastoma

Kent Riemondy
University of Colorado, Aurora - RNA Biosciences Initiative
Sujatha Venkataraman
Children’s Hospital Colorado - Morgan Adams Foundation Pediatric Brain Tumor Research Program
Posted: 07 Oct 2020
Publication Status: Review Complete
Downloads 16